Who
Wayne Joseph Riley
Director
Company insider
Files Form 4 as: Director, Heartflow; Director, COMPASS Pathways; Director, HCA Healthcare; Director, Vertex Pharmaceuticals; Director, Pinnacle Financial Partners.
In numbers
- Trades disclosed
- 71
- Buys
- 0
- Sells
- 11
- Bought
- $0
- Sold
- $8.0M
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 25 Mar 2008
- Last trade
- 16 Jun 2026
- Last filed
- 18 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jun 2026filed 18 Jun 2026 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code A | $515K16,075 at $32.05 | filing |
| 16 Jun 2026filed 18 Jun 2026 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code A | $515K16,075 at $32.05 | filing |
| 27 May 2026filed 29 May 2026 | CMPS COMPASS Pathwaysoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,110 at $0.00 | filing |
| 27 May 2026filed 29 May 2026 | CMPS COMPASS Pathwaysoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,110 at $0.00 | filing |
| 28 Apr 2026filed 30 Apr 2026 | HCA HCA HealthcareProviders & Facilities | SEC FORM 4 Code A | —509 at $0.00 | filing |
| 28 Apr 2026filed 30 Apr 2026 | HCA HCA HealthcareProviders & Facilities | SEC FORM 4 Code A | —509 at $0.00 | filing |
| 7 Aug 2025filed 11 Aug 2025 | HTFL Heartflowoption or derivative · Medical Devices | SEC FORM 4 Code A | —23,710 at $0.00 | filing |
| 12 Jun 2025filed 13 Jun 2025 | CMPS COMPASS Pathwaysoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 29 Apr 2025filed 1 May 2025 | HCA HCA HealthcareProviders & Facilities | SEC FORM 4 Code A | —645 at $0.00 | filing |
| 9 May 2024filed 13 May 2024 | CMPS COMPASS Pathwaysoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 29 Apr 2024filed 1 May 2024 | HCA HCA HealthcareProviders & Facilities | SEC FORM 4 Code A | —610 at $0.00 | filing |
| 2 Jun 2023filed 6 Jun 2023 | CMPS COMPASS Pathwaysoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 24 Apr 2023filed 26 Apr 2023 | HCA HCA HealthcareProviders & Facilities | SEC FORM 4 Code A | —663 at $0.00 | filing |
| 16 Jun 2022filed 17 Jun 2022 | CMPS COMPASS Pathwaysoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,250 at $0.00 | filing |
| 25 Apr 2022filed 27 Apr 2022 | HCA HCA HealthcareProviders & Facilities | SEC FORM 4 Code A | —902 at $0.00 | filing |
| 28 Apr 2021filed 30 Apr 2021 | HCA HCA HealthcareProviders & Facilities | SEC FORM 4 Code A | —881 at $0.00 | filing |
| 8 Mar 2021filed 10 Mar 2021 | HCA HCA HealthcareProviders & Facilities | SEC FORM 4 Sold | $314K1,650 at $190.00 | filing |
| 4 Feb 2021filed 5 Feb 2021 | HCA HCA HealthcareProviders & Facilities | SEC FORM 4 Sold | $289K1,650 at $175.00 | filing |
| 3 Feb 2021filed 5 Feb 2021 | HCA HCA HealthcareProviders & Facilities | SEC FORM 4 Sold | $274K1,650 at $166.19 | filing |
| 1 May 2020filed 5 May 2020 | HCA HCA HealthcareProviders & Facilities | SEC FORM 4 Code A | —1,668 at $0.00 | filing |
News
HCA Healthcare Foundation Awards $25,000 to Waypoint to Expand the Network of Adults Supporting Youth Mental Wellness Across VirginiaHCA · manilatimes.net · 19 Oct 2026Head to Head Analysis: Caribou Biosciences (NASDAQ:CRBU) & Vertex Pharmaceuticals (NASDAQ:VRTX)VRTX · tickerreport.com · 14 Oct 2026Vertex Pharmaceuticals Incorporated: Vertex to Present New Data on ALYFTREK at the North American Cystic Fibrosis ConferenceVRTX · finanznachrichten.de · 9 Oct 2026
0 headlines in the last 90 days name Wayne Joseph Riley; 3 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.